152 related articles for article (PubMed ID: 30318572)
21. Prevalence of Occult Malignancy Within Morcellated Specimens Removed During Laparoscopic Sacrocolpopexy.
Vallabh-Patel V; Saiz C; Salamon C; Francis A; Pagnillo J; Culligan P
Female Pelvic Med Reconstr Surg; 2016; 22(4):190-3. PubMed ID: 26945272
[TBL] [Abstract][Full Text] [Related]
22. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
[TBL] [Abstract][Full Text] [Related]
23. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go?
Brown J; Taylor K; Ramirez PT; Sun C; Holman LL; Cone SM; Irwin J; Frumovitz M
J Minim Invasive Gynecol; 2015 Feb; 22(2):185-92. PubMed ID: 25242233
[TBL] [Abstract][Full Text] [Related]
25. Uterine morcellation and survival in uterine sarcomas.
Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
[TBL] [Abstract][Full Text] [Related]
26. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
27. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
Tan A; Salfinger S; Tan J; Cohen P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
[TBL] [Abstract][Full Text] [Related]
28. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
29. Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse.
Hill AJ; Carroll AW; Matthews CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):113-5. PubMed ID: 24566217
[TBL] [Abstract][Full Text] [Related]
30. Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA.
Chang OH; Ferrando CA
J Minim Invasive Gynecol; 2021 Apr; 28(4):788-793. PubMed ID: 32681994
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic supracervical hysterectomy with transcervical morcellation: initial experience.
Rosenblatt P; Makai G; DiSciullo A
J Minim Invasive Gynecol; 2010; 17(3):331-6. PubMed ID: 20417424
[TBL] [Abstract][Full Text] [Related]
32. Non-malignant Sequelae after Unconfined Power Morcellation.
Zhang HM; Christianson LA; Templeman CL; Lentz SE
J Minim Invasive Gynecol; 2019; 26(3):434-440. PubMed ID: 29783003
[TBL] [Abstract][Full Text] [Related]
33. Incidence of unexpected uterine malignancies after electromechanical power morcellation: a retrospective multicenter analysis in Germany.
Gitas G; Alkatout I; Mettler L; Abdusattarova K; Ertan AK; Rody A; Pados G; Baum S
Arch Gynecol Obstet; 2020 Aug; 302(2):447-453. PubMed ID: 32488399
[TBL] [Abstract][Full Text] [Related]
34. Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy.
Della Badia C; Karini H
J Minim Invasive Gynecol; 2010; 17(6):791-3. PubMed ID: 20955991
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
Chen I; Hopkins L; Firth B; Boucher J; Singh SS
J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
37. Supracervical hysterectomy by laparoendoscopic single site surgery.
Estrade JP; Crochet P; Aumiphin J; Gurriet B; Marcelli M; Agostini A
Arch Gynecol Obstet; 2014 Dec; 290(6):1169-72. PubMed ID: 25012604
[TBL] [Abstract][Full Text] [Related]
38. Occult Uterine Malignancy at the Time of Surgery for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
Davenport E; James L; Parks T; Howard DL
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e282-e289. PubMed ID: 32604198
[TBL] [Abstract][Full Text] [Related]
39. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
Tulandi T; Leung A; Jan N
J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
[TBL] [Abstract][Full Text] [Related]
40. In-Bag Morcellation as a Routine for Laparoscopic Hysterectomy.
Rimbach S; Schempershofe M
Biomed Res Int; 2017; 2017():6701916. PubMed ID: 29318153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
